These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1402127)

  • 1. Potentiation of hyperthermia in a murine tumour by metabolic inhibitors rhodamine 123 and 2-deoxy-D-glucose or 5-thio-D-glucose.
    Harrigan PM; Douple EB; Wills ML
    Int J Hyperthermia; 1992; 8(4):475-83. PubMed ID: 1402127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of mammary tumors of C3H/He mice to hyperthermia and bleomycin in vivo.
    Ma F; Hiraoka M; Jo S; Akuta K; Nishimura Y; Takahashi M; Abe M
    Radiat Med; 1985; 3(4):230-3. PubMed ID: 2425397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL; Horsman MR
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Overgaard J; Horsman MR
    Int J Hyperthermia; 2001; 17(6):508-19. PubMed ID: 11719967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.
    Epelbaum R; Teicher BA; Holden SA; Ara G; Varshney A; Herman TS
    Eur J Cancer; 1992; 28A(4-5):794-800. PubMed ID: 1524897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment.
    Overgaard J; Radacic M; Skaric D; Skaric V; Horsman MR; Lindegaard JC; Jercic J
    Int J Hyperthermia; 1993; 9(6):821-30. PubMed ID: 8106823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of step-down heating on brachytherapy in a murine tumor system.
    Jones EL; Douple EB
    Radiat Res; 1990 Nov; 124(2):141-6. PubMed ID: 2247594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperthermia and/or nicotinamide on the radiation response of a C3H mammary carcinoma.
    Kjellén E; Pero RW; Nilsson P; Hill SA
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1733-7. PubMed ID: 2534381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of 2-deoxy-D-glucose and 5-thio-D-glucose to kill hypoxic cells of two murine tumors.
    Tannock IF; Guttman P; Rauth AM
    Cancer Res; 1983 Mar; 43(3):980-3. PubMed ID: 6337709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of hyperthermia effect in vivo by amiloride and DIDS.
    Lyons JC; Ross BD; Song CW
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):95-103. PubMed ID: 8416887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J; Radacic MM; Grau C
    Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.
    Murata R; Overgaard J; Horsman MR
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1018-24. PubMed ID: 11704326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4'-Epi-doxorubicin and hyperthermia in a murine mammary carcinoma: influence of the dose and fractionation.
    Cividalli A; Danesi DT; Altavista P; Bonanni M; Persiani D; Segre L; Cruciani G
    Anticancer Res; 1995; 15(3):739-43. PubMed ID: 7645951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
    Horsman MR; Overgaard J; Chaplin DJ
    Acta Oncol; 1988; 27(6b):861-2. PubMed ID: 3233175
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.
    Griffin RJ; Okajima K; Ogawa A; Song CW
    Int J Radiat Biol; 1999 Oct; 75(10):1299-306. PubMed ID: 10549607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylglyoxal bis(guanylhydrazone) on tumour and skin responses to hyperthermia in mice.
    Miyakoshi J; Hiraoka M; Oda W; Takahashi M; Abe M; Inagaki C
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Sep; 46(3):287-91. PubMed ID: 6333410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential for chemotherapy and hyperthermia.
    Bertino JR; Kowal CD; Klein ME; Dombrowski J; Mini E
    Front Radiat Ther Oncol; 1984; 18():162-70. PubMed ID: 6200385
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of the effect of an angiogenesis inhibitor on murine tumors by hyperthermia.
    Ikeda S; Akagi K; Shiraishi T; Tanaka Y
    Oncol Rep; 1998; 5(1):181-4. PubMed ID: 9458318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia and radiation in vivo: effect of 2-deoxy-D-glucose.
    Gridley DS; Nutter RL; Mantik DW; Slater JM
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):567-74. PubMed ID: 3972666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.